Fighting Chronic Pain and Neurological Disorders at DeviceTalks West
Few technologies present the promise – and face the hurdles – of the neuromodulation industry.
Unproven business models, intense clinical trials, and uncertain business models are just SOME of the challenges that have faced start-ups over the years.
In neuromodulation, these stubborn problems can cost millions in development expenses and delay the introduction of new life-saving tools and technologies.
But there is success being reported and reasons for optimism that we’ll explore at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center.
Speakers so far include:
- Ranier Birkenbach, Chief Technology Officer, Brainlab
- Rafael Carbunaru, Chief Technology Officer, Neuromodulation, Boston Scientific
- David Chernoff, CMO, Setpoint Medical
- Kurt Haggstrom, Chief Commercial Officer, Synchron
- Renee Ryan, CEO, Cala Health
- Brent Vaughan, CEO, Cognito Therapeutics
With more speakers and start-ups to be announced. Keep an eye on DeviceTalks.com/latest.
DeviceTalks attendees leave our meeting with notebooks full of critical advice and pockets full of business cards.
We’ll help fill both at DeviceTalks West.
